NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported second-quarter revenue growth of 4 percent but fell short of analysts' expectations for the top line.

The St. Louis-based research and chemical products firm reported total revenues of $664 million for the three months ended June 30, up from $637 million for the second quarter of 2011. Analysts, on average, expected sales of $674.7 million.

On an organic basis, Sigma-Aldrich's sales grew 3 percent. Acquisitions added 6 percent to sales growth, while currency exchange reduced its sales by 5 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.